FDA Inspection 1225051 — Lin Shen, M.D.
The FDA completed an inspection of Lin Shen, M.D. on Nov 17, 2023 in Haidian District. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Nov 17, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Haidian District (China)
Additional Details
Clinical Investigator (CI)